Altered DNA methylation pattern contributes to differential epigenetic immune signaling in the upper respiratory airway of COVID-19 patients

Author:

Govender MelissaORCID,Das JyotirmoyORCID,Hopkins Francis R.ORCID,Svanberg CeciliaORCID,Nordgren JohanORCID,Hagbom MarieORCID,Klingström JonasORCID,Nilsdotter-Augustinsson ÅsaORCID,Yong Yean K.,Velu VijayakumarORCID,Raju Sivadoss,Sjöwall JohannaORCID,Shankar Esaki M.ORCID,Nyström SofiaORCID,Larsson MarieORCID

Abstract

AbstractThe emergence of SARS-CoV-2 has had a profound adverse impact on global health and continues to remain a threat worldwide. The disease spectrum of COVID-19 ranges from asymptomatic to fatal clinical outcomes especially in the elderly population and in individuals with underlying medical conditions. The impact of COVID-19 on host immune responses and immune cells at the protein and DNA levels remains largely ambiguous. In a case-control study, here we explored the impact of COVID-19 on DNA methylation patterns in the upper respiratory airway to determine how SARS-CoV-2 infection altered the immune status of individuals requiring hospitalization for COVID-19. We performed DNA methylation arrays on nasopharyngeal swabs at inclusion/hospitalization as well as 6 weeks post-inclusion. Our study reveals a distinct DNA methylation pattern in COVID-19 patients compared to healthy controls, characterized by 317 779 differentially methylated CpGs. Notably, within the transcription start sites and gene body, COVID-19 patients exhibited a higher number of genes/CpGs with elevated methylation levels. Enrichment analysis of methylated genes at transcription start sites highlighted the impact on genes associated with inflammatory responses and immune functions. Some SARS-CoV-2 -induced CpG methylations were transient, returning to normal levels by 6 weeks post-inclusion. Enriched genes of interest included IL-17A, a pivotal cytokine implicated with inflammation and healing, and NUP93, associated with antiviral innate immunity. Further, six genes in our data set, OAS1, CXCR5, APP, CCL20, CNR2, and C3AR1, were found in enrichment analysis with previous COVID-19 studies. Additionally, RNAse1 and RNAse2 emerged as key regulators, while IL-18 played a role in various biological processes in COVID-19 patients. Overall, our results demonstrates that COVID-19 has a major impact on the upper airway by modifying the methylation pattern of many genes and this could have implications for the conditioning of the airways and how the individual response to future airway infections.

Publisher

Cold Spring Harbor Laboratory

Reference85 articles.

1. CDC.. COVID-19 Treatments and Medications. https://www.cdc.gov/coronavirus/2019-ncov/your-health/treatments-for-severe-illness.html (2023).

2. WHO. WHO Coronavirus (COVID-19) Dashboard.. https://covid19.who.int/ (2020 7 February 2023).

3. McIntosh, K. COVID-19: Clinical features UpToDate 2023 https://www.uptodate.com/contents/covid-19-clinical-features.

4. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations;Lancet Respir Med,2020

5. SARS-CoV-2 variant biology: immune escape, transmission and fitness;Nat Rev Microbiol,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3